Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Management of pulmonary disease in patients with cystic fibrosis
C. A. Robinson
, R. J. Kuhn
Pharmacy Practice and Science
Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of pulmonary disease in patients with cystic fibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Silo-Filler's Disease
100%
Patient with Cystic Fibrosis
100%
Infection
50%
Cystic Fibrosis
50%
Diseases
50%
Lung
25%
Lifespan
25%
Infancy
25%
Antibiotic Therapy
25%
Gas Exchange
25%
Respiratory Tract Inflammation
25%
Airway Obstruction
25%
Antibiotics
25%
Obstruction
25%
Respiratory Tract Infection
25%
Pancreas Enzyme
25%
Vitamin Supplementation
25%
Cystic Fibrosis Transmembrane Conductance Regulator
25%
Autosomal Recessive Disorder
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Lung Disease
100%
Infection
40%
Inflammation
40%
Diseases
40%
Antibiotics
20%
Antibiotic Therapy
20%
Respiratory Tract Inflammation
20%
Pancreas Enzyme
20%
Obstruction
20%
Autosomal Recessive Disorder
20%
Respiratory Tract Infection
20%
Cystic Fibrosis Transmembrane Conductance Regulator
20%
Airway Obstruction
20%